ID   H2B1F_MOUSE             Reviewed;         126 AA.
AC   P10853; Q5SZZ3;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   07-APR-2021, entry version 191.
DE   RecName: Full=Histone H2B type 1-F/J/L;
DE   AltName: Full=H2B 291A;
GN   Name=H2bc7 {ECO:0000312|MGI:MGI:2448383};
GN   Synonyms=H2b-f, Hist1h2bf {ECO:0000312|MGI:MGI:2448383};
GN   and
GN   Name=H2bc11 {ECO:0000312|MGI:MGI:2448388};
GN   Synonyms=H2b-j, Hist1h2bj {ECO:0000312|MGI:MGI:2448388};
GN   and
GN   Name=H2bc13 {ECO:0000312|MGI:MGI:2448403};
GN   Synonyms=H2b-l, Hist1h2bl {ECO:0000312|MGI:MGI:2448403};
GN   and
GN   Name=H2bc15 {ECO:0000312|MGI:MGI:2448407};
GN   Synonyms=H2b-n, Hist1h2bn {ECO:0000312|MGI:MGI:2448407};
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3562244; DOI=10.1093/nar/15.7.3023;
RA   Liu T.-J., Liu L., Marzluff W.F.;
RT   "Mouse histone H2A and H2B genes: four functional genes and a pseudogene
RT   undergoing gene conversion with a closely linked functional gene.";
RL   Nucleic Acids Res. 15:3023-3039(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=8858344; DOI=10.1101/gr.6.8.688;
RA   Wang Z.-F., Krasikov T., Frey M.R., Wang J., Matera A.G., Marzluff W.F.;
RT   "Characterization of the mouse histone gene cluster on chromosome 13: 45
RT   histone genes in three patches spread over 1Mb.";
RL   Genome Res. 6:688-701(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (H2BC7; H2BC11; H2BC13 AND H2BC15).
RX   PubMed=12408966; DOI=10.1006/geno.2002.6850;
RA   Marzluff W.F., Gongidi P., Woods K.R., Jin J., Maltais L.J.;
RT   "The human and mouse replication-dependent histone genes.";
RL   Genomics 80:487-498(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (H2BC11; H2BC13 AND H2BC15).
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [5]
RP   PHOSPHORYLATION AT SER-15.
RX   PubMed=15197225; DOI=10.1084/jem.20032247;
RA   Fernandez-Capetillo O., Allis C.D., Nussenzweig A.;
RT   "Phosphorylation of histone H2B at DNA double-strand breaks.";
RL   J. Exp. Med. 199:1671-1677(2004).
RN   [6]
RP   PHOSPHORYLATION AT SER-15.
RX   PubMed=16039583; DOI=10.1016/j.immuni.2005.05.007;
RA   Odegard V.H., Kim S.T., Anderson S.M., Shlomchik M.J., Schatz D.G.;
RT   "Histone modifications associated with somatic hypermutation.";
RL   Immunity 23:101-110(2005).
RN   [7]
RP   PHOSPHORYLATION AT SER-37.
RX   PubMed=20647423; DOI=10.1126/science.1191241;
RA   Bungard D., Fuerth B.J., Zeng P.Y., Faubert B., Maas N.L., Viollet B.,
RA   Carling D., Thompson C.B., Jones R.G., Berger S.L.;
RT   "Signaling kinase AMPK activates stress-promoted transcription via histone
RT   H2B phosphorylation.";
RL   Science 329:1201-1205(2010).
RN   [8]
RP   CROTONYLATION AT LYS-6; LYS-12; LYS-13; LYS-16; LYS-17; LYS-21; LYS-24 AND
RP   LYS-35.
RX   PubMed=21925322; DOI=10.1016/j.cell.2011.08.008;
RA   Tan M., Luo H., Lee S., Jin F., Yang J.S., Montellier E., Buchou T.,
RA   Cheng Z., Rousseaux S., Rajagopal N., Lu Z., Ye Z., Zhu Q., Wysocka J.,
RA   Ye Y., Khochbin S., Ren B., Zhao Y.;
RT   "Identification of 67 histone marks and histone lysine crotonylation as a
RT   new type of histone modification.";
RL   Cell 146:1016-1028(2011).
RN   [9]
RP   SUCCINYLATION AT LYS-121.
RX   PubMed=22389435; DOI=10.1074/mcp.m111.015875;
RA   Xie Z., Dai J., Dai L., Tan M., Cheng Z., Wu Y., Boeke J.D., Zhao Y.;
RT   "Lysine succinylation and lysine malonylation in histones.";
RL   Mol. Cell. Proteomics 11:100-107(2012).
RN   [10]
RP   HYDROXYBUTYRYLATION AT LYS-6; LYS-13; LYS-21; LYS-24; LYS-25; LYS-35;
RP   LYS-44; LYS-47; LYS-58; LYS-86; LYS-109; LYS-117 AND LYS-121.
RX   PubMed=24681537; DOI=10.1038/nchembio.1497;
RA   Dai L., Peng C., Montellier E., Lu Z., Chen Y., Ishii H., Debernardi A.,
RA   Buchou T., Rousseaux S., Jin F., Sabari B.R., Deng Z., Allis C.D., Ren B.,
RA   Khochbin S., Zhao Y.;
RT   "Lysine 2-hydroxyisobutyrylation is a widely distributed active histone
RT   mark.";
RL   Nat. Chem. Biol. 10:365-370(2014).
RN   [11]
RP   HYDROXYBUTYRYLATION AT LYS-6; LYS-12; LYS-21; LYS-35; LYS-109 AND LYS-117.
RX   PubMed=27105115; DOI=10.1016/j.molcel.2016.03.036;
RA   Xie Z., Zhang D., Chung D., Tang Z., Huang H., Dai L., Qi S., Li J.,
RA   Colak G., Chen Y., Xia C., Peng C., Ruan H., Kirkey M., Wang D.,
RA   Jensen L.M., Kwon O.K., Lee S., Pletcher S.D., Tan M., Lombard D.B.,
RA   White K.P., Zhao H., Li J., Roeder R.G., Yang X., Zhao Y.;
RT   "Metabolic regulation of gene expression by histone lysine beta-
RT   hydroxybutyrylation.";
RL   Mol. Cell 62:194-206(2016).
RN   [12]
RP   LACTYLATION AT LYS-6; LYS-12; LYS-16; LYS-17; LYS-21; LYS-86; LYS-109 AND
RP   LYS-117.
RX   PubMed=31645732; DOI=10.1038/s41586-019-1678-1;
RA   Zhang D., Tang Z., Huang H., Zhou G., Cui C., Weng Y., Liu W., Kim S.,
RA   Lee S., Perez-Neut M., Ding J., Czyz D., Hu R., Ye Z., He M., Zheng Y.G.,
RA   Shuman H.A., Dai L., Ren B., Roeder R.G., Becker L., Zhao Y.;
RT   "Metabolic regulation of gene expression by histone lactylation.";
RL   Nature 574:575-580(2019).
CC   -!- FUNCTION: Core component of nucleosome. Nucleosomes wrap and compact
CC       DNA into chromatin, limiting DNA accessibility to the cellular
CC       machineries which require DNA as a template. Histones thereby play a
CC       central role in transcription regulation, DNA repair, DNA replication
CC       and chromosomal stability. DNA accessibility is regulated via a complex
CC       set of post-translational modifications of histones, also called
CC       histone code, and nucleosome remodeling.
CC   -!- SUBUNIT: The nucleosome is a histone octamer containing two molecules
CC       each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and
CC       two H2A-H2B heterodimers. The octamer wraps approximately 147 bp of
CC       DNA.
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome.
CC   -!- PTM: Monoubiquitination at Lys-35 (H2BK34Ub) by the MSL1/MSL2 dimer is
CC       required for histone H3 'Lys-4' (H3K4me) and 'Lys-79' (H3K79me)
CC       methylation and transcription activation at specific gene loci, such as
CC       HOXA9 and MEIS1 loci. Similarly, monoubiquitination at Lys-121
CC       (H2BK120Ub) by the RNF20/40 complex gives a specific tag for epigenetic
CC       transcriptional activation and is also prerequisite for histone H3
CC       'Lys-4' and 'Lys-79' methylation. It also functions cooperatively with
CC       the FACT dimer to stimulate elongation by RNA polymerase II. H2BK120Ub
CC       also acts as a regulator of mRNA splicing: deubiquitination by USP49 is
CC       required for efficient cotranscriptional splicing of a large set of
CC       exons (By similarity). {ECO:0000250|UniProtKB:P33778}.
CC   -!- PTM: Phosphorylated on Ser-15 (H2BS14ph) by STK4/MST1 during apoptosis;
CC       which facilitates apoptotic chromatin condensation. Also phosphorylated
CC       on Ser-15 in response to DNA double strand breaks (DSBs), and in
CC       correlation with somatic hypermutation and immunoglobulin class-switch
CC       recombination. Phosphorylation at Ser-37 (H2BS36ph) by AMPK in response
CC       to stress promotes transcription. {ECO:0000269|PubMed:15197225,
CC       ECO:0000269|PubMed:16039583, ECO:0000269|PubMed:20647423}.
CC   -!- PTM: GlcNAcylation at Ser-113 promotes monoubiquitination of Lys-121.
CC       It fluctuates in response to extracellular glucose, and associates with
CC       transcribed genes (By similarity). {ECO:0000250|UniProtKB:P62807}.
CC   -!- PTM: Crotonylation (Kcr) is specifically present in male germ cells and
CC       marks testis-specific genes in post-meiotic cells, including X-linked
CC       genes that escape sex chromosome inactivation in haploid cells.
CC       Crotonylation marks active promoters and enhancers and confers
CC       resistance to transcriptional repressors. It is also associated with
CC       post-meiotically activated genes on autosomes.
CC       {ECO:0000269|PubMed:21925322}.
CC   -!- PTM: Hydroxybutyrylation of histones is induced by starvation.
CC       {ECO:0000269|PubMed:27105115}.
CC   -!- PTM: Lactylated in macrophages by EP300/P300 by using lactoyl-CoA
CC       directly derived from endogenous or exogenous lactate, leading to
CC       stimulates gene transcription. {ECO:0000250|UniProtKB:P33778}.
CC   -!- SIMILARITY: Belongs to the histone H2B family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X05862; CAA29290.1; -; Genomic_DNA.
DR   EMBL; U62669; AAB04762.1; -; Genomic_DNA.
DR   EMBL; AY158927; AAO06237.1; -; Genomic_DNA.
DR   EMBL; AY158929; AAO06239.1; -; Genomic_DNA.
DR   EMBL; AY158932; AAO06242.1; -; Genomic_DNA.
DR   EMBL; AY158935; AAO06245.1; -; Genomic_DNA.
DR   EMBL; AL589651; CAI24103.1; -; Genomic_DNA.
DR   EMBL; AL589651; CAI24111.1; -; Genomic_DNA.
DR   EMBL; AL589879; CAI25462.1; -; Genomic_DNA.
DR   EMBL; AL589879; CAI25467.1; -; Genomic_DNA.
DR   EMBL; AL590614; CAI26130.1; -; Genomic_DNA.
DR   CCDS; CCDS26287.1; -.
DR   CCDS; CCDS26294.1; -.
DR   CCDS; CCDS26308.1; -.
DR   CCDS; CCDS26350.1; -.
DR   PIR; S04151; S04151.
DR   RefSeq; NP_001300807.1; NM_001313878.1.
DR   RefSeq; NP_001300809.1; NM_001313880.1.
DR   RefSeq; NP_835502.1; NM_178195.2.
DR   RefSeq; NP_835505.1; NM_178198.2.
DR   RefSeq; NP_835506.1; NM_178199.2.
DR   RefSeq; NP_835508.1; NM_178201.2.
DR   SMR; P10853; -.
DR   BioGRID; 235099; 1.
DR   BioGRID; 235104; 1.
DR   ComplexPortal; CPX-5705; CENP-A nucleosome complex.
DR   ComplexPortal; CPX-5712; Nucleosome, variant H3.1-H2A.2-H2B.1.
DR   ComplexPortal; CPX-5713; Nucleosome, variant H3.2-H2A.2-H2B.1.
DR   ComplexPortal; CPX-5714; Nucleosome, variant H3.g-H2A.2-H2B.1.
DR   ComplexPortal; CPX-5715; Nucleosome, variant H3.1-H2A.Z-H2B.1.
DR   ComplexPortal; CPX-5716; Nucleosome, variant H3.1-H2A.V-H2B.1.
DR   IntAct; P10853; 2.
DR   MINT; P10853; -.
DR   STRING; 10090.ENSMUSP00000106082; -.
DR   GlyGen; P10853; 1 site.
DR   iPTMnet; P10853; -.
DR   PhosphoSitePlus; P10853; -.
DR   SwissPalm; P10853; -.
DR   jPOST; P10853; -.
DR   MaxQB; P10853; -.
DR   PaxDb; P10853; -.
DR   PeptideAtlas; P10853; -.
DR   PRIDE; P10853; -.
DR   ProteomicsDB; 271121; -.
DR   TopDownProteomics; P10853; -.
DR   DNASU; 319180; -.
DR   Ensembl; ENSMUST00000091709; ENSMUSP00000089301; ENSMUSG00000095217.
DR   Ensembl; ENSMUST00000091756; ENSMUSP00000089350; ENSMUSG00000094338.
DR   Ensembl; ENSMUST00000105106; ENSMUSP00000100738; ENSMUSG00000069268.
DR   Ensembl; ENSMUST00000110452; ENSMUSP00000106082; ENSMUSG00000069300.
DR   Ensembl; ENSMUST00000110467; ENSMUSP00000106093; ENSMUSG00000069303.
DR   Ensembl; ENSMUST00000110469; ENSMUSP00000106095; ENSMUSG00000069307.
DR   GeneID; 319180; -.
DR   GeneID; 319183; -.
DR   GeneID; 319185; -.
DR   GeneID; 319187; -.
DR   GeneID; 665596; -.
DR   GeneID; 665622; -.
DR   KEGG; mmu:319180; -.
DR   KEGG; mmu:319183; -.
DR   KEGG; mmu:319185; -.
DR   KEGG; mmu:319187; -.
DR   KEGG; mmu:665596; -.
DR   KEGG; mmu:665622; -.
DR   UCSC; uc007pra.2; mouse.
DR   CTD; 665596; -.
DR   CTD; 665622; -.
DR   CTD; 8340; -.
DR   CTD; 8341; -.
DR   CTD; 8343; -.
DR   CTD; 8970; -.
DR   MGI; MGI:2448388; H2bc11.
DR   MGI; MGI:2448403; H2bc13.
DR   MGI; MGI:2448407; H2bc15.
DR   MGI; MGI:2448383; H2bc7.
DR   eggNOG; KOG1744; Eukaryota.
DR   GeneTree; ENSGT01020000230504; -.
DR   HOGENOM; CLU_075666_2_1_1; -.
DR   InParanoid; P10853; -.
DR   OMA; YTSANIM; -.
DR   OrthoDB; 1536672at2759; -.
DR   PhylomeDB; P10853; -.
DR   TreeFam; TF300212; -.
DR   Reactome; R-MMU-110330; Recognition and association of DNA glycosylase with site containing an affected purine.
DR   Reactome; R-MMU-110331; Cleavage of the damaged purine.
DR   Reactome; R-MMU-212300; PRC2 methylates histones and DNA.
DR   Reactome; R-MMU-2299718; Condensation of Prophase Chromosomes.
DR   Reactome; R-MMU-2559586; DNA Damage/Telomere Stress Induced Senescence.
DR   Reactome; R-MMU-3214815; HDACs deacetylate histones.
DR   Reactome; R-MMU-3214847; HATs acetylate histones.
DR   Reactome; R-MMU-5693565; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks.
DR   Reactome; R-MMU-5693571; Nonhomologous End-Joining (NHEJ).
DR   Reactome; R-MMU-5693607; Processing of DNA double-strand break ends.
DR   Reactome; R-MMU-606279; Deposition of new CENPA-containing nucleosomes at the centromere.
DR   Reactome; R-MMU-69473; G2/M DNA damage checkpoint.
DR   Reactome; R-MMU-8866654; E3 ubiquitin ligases ubiquitinate target proteins.
DR   Reactome; R-MMU-8936459; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function.
DR   Reactome; R-MMU-9018519; Estrogen-dependent gene expression.
DR   Reactome; R-MMU-9670095; Inhibition of DNA recombination at telomere.
DR   BioGRID-ORCS; 319180; 8 hits in 18 CRISPR screens.
DR   BioGRID-ORCS; 319183; 7 hits in 21 CRISPR screens.
DR   BioGRID-ORCS; 319185; 8 hits in 17 CRISPR screens.
DR   BioGRID-ORCS; 319187; 9 hits in 19 CRISPR screens.
DR   BioGRID-ORCS; 665596; 2 hits in 5 CRISPR screens.
DR   BioGRID-ORCS; 665622; 2 hits in 3 CRISPR screens.
DR   PRO; PR:P10853; -.
DR   Proteomes; UP000000589; Chromosome 13.
DR   RNAct; P10853; protein.
DR   Bgee; ENSMUSG00000069268; Expressed in undifferentiated genital tubercle and 50 other tissues.
DR   Genevisible; P10853; MM.
DR   GO; GO:0005829; C:cytosol; ISO:MGI.
DR   GO; GO:0005615; C:extracellular space; ISO:MGI.
DR   GO; GO:0005654; C:nucleoplasm; ISO:MGI.
DR   GO; GO:0000786; C:nucleosome; IEA:UniProtKB-KW.
DR   GO; GO:0005634; C:nucleus; ISO:MGI.
DR   GO; GO:0003677; F:DNA binding; IBA:GO_Central.
DR   GO; GO:0042802; F:identical protein binding; ISO:MGI.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro.
DR   GO; GO:0019731; P:antibacterial humoral response; ISO:MGI.
DR   GO; GO:0061844; P:antimicrobial humoral immune response mediated by antimicrobial peptide; ISO:MGI.
DR   GO; GO:0050830; P:defense response to Gram-positive bacterium; ISO:MGI.
DR   GO; GO:0002227; P:innate immune response in mucosa; ISO:MGI.
DR   GO; GO:0006334; P:nucleosome assembly; IBA:GO_Central.
DR   Gene3D; 1.10.20.10; -; 1.
DR   InterPro; IPR009072; Histone-fold.
DR   InterPro; IPR007125; Histone_H2A/H2B/H3.
DR   InterPro; IPR000558; Histone_H2B.
DR   PANTHER; PTHR23428; PTHR23428; 1.
DR   Pfam; PF00125; Histone; 1.
DR   PRINTS; PR00621; HISTONEH2B.
DR   SMART; SM00427; H2B; 1.
DR   SUPFAM; SSF47113; SSF47113; 1.
DR   PROSITE; PS00357; HISTONE_H2B; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Chromosome; DNA-binding; Glycoprotein; Hydroxylation;
KW   Isopeptide bond; Methylation; Nucleosome core; Nucleus; Phosphoprotein;
KW   Reference proteome; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P23527"
FT   CHAIN           2..126
FT                   /note="Histone H2B type 1-F/J/L"
FT                   /id="PRO_0000071839"
FT   MOD_RES         2
FT                   /note="N-acetylproline"
FT                   /evidence="ECO:0000250|UniProtKB:P23527"
FT   MOD_RES         6
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         6
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         6
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P33778"
FT   MOD_RES         6
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P33778"
FT   MOD_RES         6
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         6
FT                   /note="N6-lactoyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31645732"
FT   MOD_RES         12
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         12
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62807"
FT   MOD_RES         12
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         12
FT                   /note="N6-lactoyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31645732"
FT   MOD_RES         13
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         13
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P33778"
FT   MOD_RES         13
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         15
FT                   /note="Phosphoserine; by STK4/MST1"
FT                   /evidence="ECO:0000269|PubMed:15197225,
FT                   ECO:0000269|PubMed:16039583"
FT   MOD_RES         16
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P33778"
FT   MOD_RES         16
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         16
FT                   /note="N6-lactoyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31645732"
FT   MOD_RES         17
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P33778"
FT   MOD_RES         17
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         17
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P33778"
FT   MOD_RES         17
FT                   /note="N6-lactoyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31645732"
FT   MOD_RES         21
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         21
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         21
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P33778"
FT   MOD_RES         21
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P33778"
FT   MOD_RES         21
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         21
FT                   /note="N6-lactoyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31645732"
FT   MOD_RES         24
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         24
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P33778"
FT   MOD_RES         24
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         24
FT                   /note="N6-lactoyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P33778"
FT   MOD_RES         25
FT                   /note="N6-(2-hydroxyisobutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         35
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         35
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         35
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         35
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P33778"
FT   MOD_RES         35
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P33778"
FT   MOD_RES         37
FT                   /note="Phosphoserine; by AMPK"
FT                   /evidence="ECO:0000269|PubMed:20647423"
FT   MOD_RES         44
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         44
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P33778"
FT   MOD_RES         44
FT                   /note="N6-lactoyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P33778"
FT   MOD_RES         47
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         47
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P33778"
FT   MOD_RES         47
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62807"
FT   MOD_RES         58
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62807"
FT   MOD_RES         58
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         80
FT                   /note="Dimethylated arginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         86
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         86
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         86
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         86
FT                   /note="N6-lactoyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31645732"
FT   MOD_RES         87
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         93
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         109
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         109
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         109
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P33778"
FT   MOD_RES         109
FT                   /note="N6-lactoyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31645732"
FT   MOD_RES         109
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62807"
FT   MOD_RES         116
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q00729"
FT   MOD_RES         117
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         117
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         117
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P33778"
FT   MOD_RES         117
FT                   /note="N6-lactoyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31645732"
FT   MOD_RES         117
FT                   /note="N6-methylated lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q00729"
FT   MOD_RES         117
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P33778"
FT   MOD_RES         121
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         121
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P33778"
FT   MOD_RES         121
FT                   /note="N6-lactoyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P33778"
FT   MOD_RES         121
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   CARBOHYD        113
FT                   /note="O-linked (GlcNAc) serine"
FT                   /evidence="ECO:0000250|UniProtKB:P62807"
FT   CROSSLNK        6
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P58876"
FT   CROSSLNK        21
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q5QNW6"
FT   CROSSLNK        35
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P33778"
FT   CROSSLNK        121
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62808"
SQ   SEQUENCE   126 AA;  13936 MW;  FAE15CE99FC8B03D CRC64;
     MPEPAKSAPA PKKGSKKAVT KAQKKDGKKR KRSRKESYSV YVYKVLKQVH PDTGISSKAM
     GIMNSFVNDI FERIASEASR LAHYNKRSTI TSREIQTAVR LLLPGELAKH AVSEGTKAVT
     KYTSSK
//
